XML 21 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Ordinary Shares
Share capital and additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Total
Balance at Dec. 31, 2019   $ 82,545 $ (233) $ (69,755) $ 12,557
Balance (in Shares) at Dec. 31, 2019 4,257,790        
Issuance of Ordinary Shares in connection with a Standby Equity Distribution Agreement, net (see Note 14.a.1)   23 23
Issuance of Ordinary Shares in connection with a Standby Equity Distribution Agreement, net (see Note 14.a.1) (in Shares) 41,090        
Share based compensation expense   77 77
Share based compensation expense (in Shares) 7,665        
Expenses underlying shelf registration   (41) (41)
Warrants underlying loan agreement (see Note 14.a.5)   30 30
Exercise of options   193 193
Exercise of options (in Shares) 84,618        
Other comprehensive loss   (10) (10)
Net income (Loss)   (960) (960)
Balance at Dec. 31, 2020   82,827 (243) (70,715) 11,869
Balance (in Shares) at Dec. 31, 2020 4,391,163        
Share based compensation expense   94 94
Share based compensation expense (in Shares) 7,188        
Issuance of Ordinary Shares in connection with Prospectus Supplement   1,814 1,814
Issuance of Ordinary Shares in connection with Prospectus Supplement (in Shares) 800,000        
Exercise of options   119 119
Exercise of options (in Shares) 52,167        
Net income (Loss)   451 451
Balance at Dec. 31, 2021   84,854 (243) (70,264) 14,347
Balance (in Shares) at Dec. 31, 2021 5,250,518        
Share based compensation expense   241 (144) 97
Issuance of Ordinary Shares in connection with Prospectus Supplement   912 912
Issuance of Ordinary Shares in connection with Prospectus Supplement (in Shares) 450,000        
Exercise of options   2 2
Exercise of options (in Shares) 1,000        
Net income (Loss)   1,276 1,276
Balance at Dec. 31, 2022   $ 86,009 $ (243) $ (69,132) $ 16,634
Balance (in Shares) at Dec. 31, 2022 5,701,518